Belumosudil and ruxolitinib combination for treatment of refractory chronic graft-versus-host disease

被引：0
|
作者：
Iskra Pusic
Catherine Lee
Muthu Veeraputhiran
Chelsea Minor
John F. DiPersio
机构：
[1] Washington University School of Medicine,Fred Hutchinson Cancer Center
[2] Division of Oncology,undefined
[3] Clinical Research Division,undefined
[4] University of Arkansas for Medical Sciences,undefined
[5] Department of Hematology and Medical Oncology,undefined
来源：
Bone Marrow Transplantation | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：282 / 284
页数：2
相关论文
共 50 条
  • [31] Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
    Zeiser, Robert
    von Bubnoff, Nikolas
    Butler, Jason
    Mohty, Mohamad
    Niederwieser, Dietger
    Or, Reuven
    Szer, Jeff
    Wagner, Eva M.
    Zuckerman, Tsila
    Mahuzier, Bruyere
    Xu, Judith
    Wilke, Celine
    Gandhi, Kunal K.
    Socie, Gerard
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1800 - 1810
  • [32] Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-Versus-Host Disease
    Gaskill, Eric
    Padilla, Maya
    Faramand, Rawan
    Lazaryan, Aleksandr
    Khimani, Farhad
    Perez, Lia
    Pidala, Joseph
    Gonzalez, Rebecca
    BLOOD, 2022, 140 : 10512 - 10513
  • [33] A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease
    Bhatt, Vijaya Raj
    Shostrom, Valerie K.
    Choe, Hannah K.
    Hamilton, Betty K.
    Gundabolu, Krishna
    Maness, Lori J.
    Kumar, Virender
    Mahato, Ram I.
    Smith, Lynette M.
    Nishihori, Taiga
    Lee, Stephanie J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (33)
  • [34] Budget Impact Analysis of Belumosudil for Chronic Graft-Versus-Host Disease Treatment in the United States
    Bachier, Carlos
    Skaar, Jeffrey Rolf
    Dehipawala, Sumudu
    Miao, Benjamin
    Ieyoub, Jonathan
    Taite, Haya
    BLOOD, 2021, 138 : 1903 - +
  • [35] Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease
    Gonzalez, Rebecca
    Gaskill, Eric
    Padilla, Maya
    Pidala, Joseph
    Lazaryan, Aleksandr
    Perez, Lia
    Khimani, Farhad
    Faramand, Rawan
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (09): : 577.e1 - 577.e9
  • [36] Budget impact analysis of belumosudil for chronic graft-versus-host disease treatment in the United States
    Bachier, Carlos R.
    Skaar, Jeffrey R.
    Dehipawala, Sumudu
    Miao, Benjamin
    Ieyoub, Jonathan
    Taitel, Haya
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 857 - 863
  • [37] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Ferreira, Aliana Meneses
    Pontes da Silva, Carolina Atallah
    Pereira, Andre Domingues
    Szor, Roberta Shcolnik
    Brito Medeiros da Fonseca, Ana Rita
    Serpa, Mariana Gomes
    Xavier, Erick Menezes
    Sampaio de Melo, Michelly Kerly
    Novis, Yana
    Tucunduva, Luciana
    Rocha, Vanderson
    Arrais-Rodrigues, Celso
    BONE MARROW TRANSPLANTATION, 2018, 53 (04) : 503 - 506
  • [38] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Aliana Meneses Ferreira
    Carolina Atallah Pontes da Silva
    André Domingues Pereira
    Roberta Shcolnik Szor
    Ana Rita Brito Medeiros da Fonseca
    Mariana Gomes Serpa
    Erick Menezes Xavier
    Michelly Kerly Sampaio de Melo
    Yana Novis
    Luciana Tucunduva
    Vanderson Rocha
    Celso Arrais-Rodrigues
    Bone Marrow Transplantation, 2018, 53 : 503 - 506
  • [39] Improving treatment of refractory chronic extensive graft-versus-host disease
    Elez, M.
    Stamatovic, D.
    Tukic, L.
    Tarabar, O.
    Balint, B.
    Skuletic, V.
    Tasic, O.
    Simic, L.
    Malesevic, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S413 - S414
  • [40] Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis
    Denk, Alexander
    Mittermaier, Cornelia
    Weber, Daniela
    Fante, Matthias
    Gunes, Sibel
    Edinger, Matthias
    Herr, Wolfgang
    Wolff, Daniel
    ANNALS OF HEMATOLOGY, 2024, 103 (09) : 3755 - 3764
12345